Eyal Orion
Founder & CEO
Claimed by owner Vascular Graft Solutions
Former names:
Hybrid Conduit for Bypass Surgery
Vascular Graft Solutions
www.prnewswire.com
•
Jan 6, 2020
Vascular Graft Solutions Acquires the Intellectual Property Developed by Kipsbay Medical Inc.
www.prnewswire.com
•
Aug 5, 2019
Vascular Graft Solutions Announces CE Mark Approval for FRAME FR External Support for AV Fistula Repair
cardiothoracicsurgery.biomedcentral.com
•
Nov 19, 2018
Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial - Journal of Cardiothoracic Surgery
www.prnewswire.com
•
Oct 18, 2018
Vascular Graft Solutions Honored by Goldman Sachs for Entrepreneurship as Eyal Orion, Its Founder and CEO, is Among 100 Most Intriguing Entrepreneurs at 2018 Builders + Innovators Summit
www.prnewswire.com
•
Aug 20, 2018
Vascular Graft Solutions Reports the First Clinical Use of Its FRAME External Support Technology in Aneurysm Repair of High Flow Arteriovenous Fistulas
www.prnewswire.com
•
Aug 1, 2018
John Radcliffe Oxford University Hospital is the First Medical Center in the UK to Use VEST Technology in Patients Undergoing Coronary Bypass Surgery
www.prnewswire.com
•
Apr 23, 2018
VGS Initiates U.S. Pivotal Trial to Evaluate the Use of Its VEST Technology for Bypass Surgery
www.prnewswire.com
•
Feb 23, 2018
Vascular Graft Solutions: External Stenting of Vein Grafts is Associated With High Early Patency Rates
academic.oup.com
•
Apr 3, 2017
prospective study of external stenting of saphenous vein grafts to the right coronary artery: the VEST II study
academic.oup.com
•
Nov 30, 2015
OCT imaging of aorto-coronary vein graft pathology modified by external stenting: 1-year post-surgery
cardiothoracicsurgery.biomedcentral.com
•
May 6, 2013
Expandable external support device to improve Saphenous Vein Graft Patency after CABG - Journal of Cardiothoracic Surgery
About
Vascular Graft Solutions (VGS) develops technologies to improve surgical revascularization, vascular reconstruction procedures, and arteriovenous fistulas.
The company's portfolio includes VEST, an external support for vein grafts in coronary artery bypass surgery, and FRAME, an external support for vein grafts in peripheral revascularization and reconstruction procedures. These devices are designed to target the underlying factors leading to saphenous vein graft disease, including disturbed flow pattern and high wall tension, diameter mismatch between the graft and the hosting artery, and, in particular, progression of intimal hyperplasia.
VEST received CE mark approval in 2014 and is commercialized in international markets. FRAME received CE mark approval in late 2017 and is commercialized for several indications, including above- and below-the-knee bypass surgeries and peripheral aneurysm repair.
Ongoing IDE-approved studies are being conducted in leading centers in the United States and Canada toward the commercialization of VGS products in the United States. VGS has additional pipeline products in various stages of research and development.
The company's portfolio includes VEST, an external support for vein grafts in coronary artery bypass surgery, and FRAME, an external support for vein grafts in peripheral revascularization and reconstruction procedures. These devices are designed to target the underlying factors leading to saphenous vein graft disease, including disturbed flow pattern and high wall tension, diameter mismatch between the graft and the hosting artery, and, in particular, progression of intimal hyperplasia.
VEST received CE mark approval in 2014 and is commercialized in international markets. FRAME received CE mark approval in late 2017 and is commercialized for several indications, including above- and below-the-knee bypass surgeries and peripheral aneurysm repair.
Ongoing IDE-approved studies are being conducted in leading centers in the United States and Canada toward the commercialization of VGS products in the United States. VGS has additional pipeline products in various stages of research and development.
Primary Sector
Life Sciences & HealthTech
Products
FRAME, VEST, FRAME FR, VIOLA
Geographic markets
Greece, Switzerland, Spain, Austria, United Kingdom, Israel, New Zealand, Germany, South Africa, Italy, Europe
News
(11)
www.prnewswire.com
•
Jan 6, 2020
Vascular Graft Solutions Acquires the Intellectual Property Developed by Kipsbay Medical Inc.
www.prnewswire.com
•
Aug 5, 2019
Vascular Graft Solutions Announces CE Mark Approval for FRAME FR External Support for AV Fistula Repair
cardiothoracicsurgery.biomedcentral.com
•
Nov 19, 2018
Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial - Journal of Cardiothoracic Surgery
www.prnewswire.com
•
Oct 18, 2018
Vascular Graft Solutions Honored by Goldman Sachs for Entrepreneurship as Eyal Orion, Its Founder and CEO, is Among 100 Most Intriguing Entrepreneurs at 2018 Builders + Innovators Summit
www.prnewswire.com
•
Aug 20, 2018
Vascular Graft Solutions Reports the First Clinical Use of Its FRAME External Support Technology in Aneurysm Repair of High Flow Arteriovenous Fistulas
www.prnewswire.com
•
Aug 1, 2018
John Radcliffe Oxford University Hospital is the First Medical Center in the UK to Use VEST Technology in Patients Undergoing Coronary Bypass Surgery
www.prnewswire.com
•
Apr 23, 2018
VGS Initiates U.S. Pivotal Trial to Evaluate the Use of Its VEST Technology for Bypass Surgery
www.prnewswire.com
•
Feb 23, 2018
Vascular Graft Solutions: External Stenting of Vein Grafts is Associated With High Early Patency Rates
academic.oup.com
•
Apr 3, 2017
prospective study of external stenting of saphenous vein grafts to the right coronary artery: the VEST II study
academic.oup.com
•
Nov 30, 2015
OCT imaging of aorto-coronary vein graft pathology modified by external stenting: 1-year post-surgery
cardiothoracicsurgery.biomedcentral.com
•
May 6, 2013
Expandable external support device to improve Saphenous Vein Graft Patency after CABG - Journal of Cardiothoracic Surgery
The Team
(2)
EO
RGK
Rotem Guez Katzenellenbogen
VP BD
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
A Round
$1.5M
Jan 2011
1 Investors
$1.5M
A Round
$1M
Feb 2012
1 Investors
$1M
B Round
$2M
Feb 2014
1 Investors
$2M
Non-Equity Funding
Grant
$300K
Jul 2011
1 Grantors
$300K
Media gallery
(4)
VEST Threading using Tourniquet
FRAME External Support for
VEST Instructions for Use
Locations
Israel
Raoul Wallenberg 24, Tel Aviv-Yafo, Israel
Locations
Israel
Raoul Wallenberg 24, Tel Aviv-Yafo, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,